DSIP has been studied for decades, but the evidence remains limited, mixed, and not strong enough to treat it as a proven solution for insomnia or sleep disorders
More information Session/Presentation: C21 From Orexin Agonists to Oxybutynin: a New Era of Pharmacologic Therapies in Sleep Medicine Tirzepatide Outcome Prediction Using Sleep Apnea Endotyping in SURMOUNT-OSA Date and Time: Tuesday, May 19 at 10:27 am ET Location: W110A (Level I, OCCC West Concourse)
10.1016/j.ctim.2019.02.017 Complement
Ireland PJ, Hardy T, Burt AD, Donnelly MC
Ilya Yuffa, Lilly USAs EVP and president, told HR Brew via email that the models are designed to provide clarity on medicine costs and flexibility for employers to determine the right benefit design for their companies and employees, and said more details will be available in 2026
How do I use Wegovy